NCT01602887 - Relative Bioavailability Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions

Healthy

Interventions

DRUG

PD-0332991

isethionate hard capsule, 125 mg, single dose

DRUG

PD-0332991

"freebase hard capsule with a small particle size, 125 mg, single dose"

DRUG

PD-0332991

"freebase hard capsule with a large particle size, 125 mg, single dose"

DRUG

PD-0332991

oral solution, 50 mg, single dose

Trial Locations (1)

Pfizer Investigational Site, New Haven